Medicare Rx Should Be Model For Covering Uninsured, PhRMA's Holmer Says
This article was originally published in The Pink Sheet Daily
Executive Summary
"Principles" of private sector-driven cost containment can be applied to expanding insurance coverage, PhRMA CEO says. Holmer urges critics of Medicare law to accept that new drug benefit will be created, and focus on ensuring successful implementation.
You may also be interested in...
PhRMA Agenda For 2005 Includes Medicare Start-Up, Liability Reform
Trade association will work on medical malpractice issues particularly at the state level. "Access & Affordability" initiative includes support for expanding coverage to the uninsured, and continued efforts around patient assistance programs.
US FDA Alzheimer Guidance Update Reflects Changes In Biomarkers – And Leadership
Latest update to draft guidance on early Alzheimer’s drug development is the third iteration of a document first published in 2013. The history of the guidance is a reflection of structural and leadership changes in the neurology review team at FDA.
Biden’s Co-Pay Cap Is Silver Lining For Pharma In Drug Pricing Campaign
President Biden’s call to expand the US Medicare price negotiation program is naturally making headlines from his campaign-year State of the Union Address. But his call for a national cap on co-pays could be an important opportunity for industry in the years to come.